{"cdcTestId":"2022-0078","testcaseName":"Patient is administered dose #1 as AstraZeneca, dose #2 as Pfizer Covid-19 , dose #3 Bivalent booster","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not Recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1997-07-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-07-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"300","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-19T00:00:00","vaccineName":"AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)","cvx":"210","mvx":"ASZ","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-16T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-16T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"300","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-09-27T12:11:46.402","generalDescription":"This test case describes when a patient is administered a first dose of  AstraZeneca Covid-19 Vaccine, second dose as Pfizer Covid-19, and third dose as bivalent Pfizer booster that the doses are valid.  Series is complete.","changedInVersion":"4.27","reasonForChange":""}